Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants

Clinical trial NCT05844423 · COMPLETED

Trial details

NCT number: NCT05844423
Sponsor: Vaxcyte, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pneumococcal Vaccines

Start date: 2023-03-29
Primary completion: 2025-08-25
Enrollment: 802

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.